Conflict of interest
Bibombe P Mwipatayi is a consultant with Medtronic, Getinge, Boston Scientific, and Biotronik and receives honoraria and research grants from Getinge, BD BARD, and Biotronik. Thomas Zeller (1) received honoraria from Abbott Vascular, Veryan, Biotronik, Boston Scientific Corp., Cook Medical, Gore & Associates, Medtronic, Philips-Spectranetics, Shockwave, and BIBA Medical; (2) consulted for Boston Scientific Corp., Gore & Associates, Medtronic, Veryan, Intact Vascular, Shockwave, Bayer, and Vesper Medical; (3) received research, clinical trial, or drug study funds from 480 biomedical, Bard Peripheral Vascular, Veryan, Biotronik, Cook Medical, Gore & Associates, Medtronic, Philips, Terumo, TriReme, Shockwave, Med Alliance, Intact Vascular, and B. Braun; and (4) has common stock in QT Medical. Marianne Brodmann (1) received honoraria from Abbott Vascular, Biotronik, Boston Scientific Corp., Cook Medical, Medtronic, Philips-Spectranetics, Shockwave, and BD Bard and (2) consulted for Abbott Vascular, Biotronik, Boston Scientific Corp., Cook Medical, Medtronic, Philips-Spectranetics, Shockwave, BD Bard, Reflow Medical, Cagent, MedAlliance, Intact Vascular, and Bolt Medical. Gunnar Tepe received research, clinical trial, or drug study funds from Bayer Health Care, BBraun, Boston Scientific, BARD, Biotronic, Gore, Medtronic, Philips, and Shockwave. The other authors have no conflict of interest to declare.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Consent for Publication
For this type of study, consent for publication is not required.
Comments (0)